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HIGHLIGHTS 24 
 Critical illness is a state of extreme physiological stress. 25 
 Physiological stress is also encountered in austere environments. 26 
 Cellular and molecular responses determine adaptation to austere 27 
environments. 28 
 Lessons learnt from survival of extreme environmental conditions may 29 
benefit critically ill patients.  30 
 31 
ABSTRACT 32 
The harshest environment that many people will ever face is the critical care 33 
unit, where pathology can stress homeostatic mechanisms beyond their limits, 34 
leading to multiple organ failure and death. Our understanding of the biology 35 
that underlies this catastrophic process remains limited. There is significant 36 
variation in survival between individuals with apparently similar severity of 37 
organ dysfunction and it is difficult to predict which patients will weather the 38 
storm. Survival may be influenced by as yet undiscovered innate adaptive 39 
mechanisms that determine an individual’s ability to tolerate physiological 40 
stress.  Identifying favourable phenotypes, and the molecular machinery 41 
underlying them, could yield new therapeutic targets to improve outcome in 42 
life-threatening illness. Unfortunately, the complexity of critical illness makes it 43 
difficult to elucidate subtle adaptive mechanisms that could favour survival 44 
during stress. However, comparisons can be drawn between the stress of 45 
critical illness and that imposed by austere environments. The Earth is 46 
comprised of a wide range of different physical environments, each of which 47 
challenges homeostasis. Whilst technological advances have played a 48 
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significant role in our capacity to survive in austere environments, biological 49 
adaptation and evolutionary change have been crucial. Studying human 50 
responses to environmental stressors such as heat, cold, hypoxia and 51 
microgravity has taught us a great deal about innate human adaptation, from 52 
the system to the cellular level, and the field continues to expand. Translating 53 
this to the pathophysiological stress of critical illness could offer alternative 54 
approaches to the current practice of intensive care medicine. 55 
 56 
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BACKGROUND 61 
The human body possesses complex mechanisms to ensure that multiple 62 
systems, from micro to macro, oscillate around their natural set point, and this 63 
is referred to as homeostasis. Deviation from the set point represents 64 
physiological stress, and can lead to cell damage and death.  Survival during 65 
physiological stress rests on the ability to adapt, and adaptation may occur at 66 
the system, organ, tissue and cellular level [1].  Critical illness occurs when 67 
the body fails to compensate for severe pathophysiological stress, brought 68 
about by illness or injury.  Much remains unknown about the precise 69 
mechanisms that lead to multiple organ failure and death, and more 70 
understanding is required to reduce mortality and morbidity from critical 71 
illness. 72 
 73 
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ADAPTATION AT THE SYSTEM VERSUS THE CELL LEVEL? 74 
We are often able to observe the response to a stressor at the system level.  75 
Such phenotypic responses tend to counter the disturbance, in an attempt to 76 
shield the cells from potential harm.  Although invaluable in surviving a 77 
temporary perturbation, such global responses may fail to buffer an excessive 78 
or indefinite onslaught.  They incur an energetic cost or physiological strain, 79 
which ultimately limits their effectiveness as a survival strategy.  For example, 80 
a rise in core temperature may be counteracted by an increase in sweat rate 81 
(in order to protect the cells from heat stress), but this response will ultimately 82 
result in dehydration and cardiovascular collapse. The greater the disturbance 83 
to homeostasis, the greater the potential devastation wreaked by the 84 
response to correct it.  This conflict is a fundamental dilemma in critical care 85 
medicine, where we attempt to support homeostasis at the system level, by 86 
targeting ‘normal’ values for measures such as global oxygenation or 87 
haemodynamics. Although this can yield improvements in outcomes during 88 
the acute phase of illness [2], once critical illness is established, such 89 
strategies may no longer convey benefit [3]. There is uncertainty regarding 90 
the range of physiological values that should be targeted in these patients 91 
without causing more harm than good [4]. The significant variability in 92 
outcomes for patients with apparently similar disease burden and treatment 93 
implies that survivors of physiological stress possess superior adaptive 94 
mechanisms, conferred by genetic variation or previous exposure to stress. 95 
Identifying survivor phenotypes, and the molecular pathways underlying their 96 
expression may yield targets for therapeutic intervention during critical illness.  97 
Distinguishing such phenotypes in critically ill patients is challenging. They 98 
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may be subtle and easily obscured by the multitude of variables influencing 99 
outcome in these patients, including age and co-morbidity, the character and 100 
duration of critical illness, and the effects of medical interventions.  Limited 101 
inferences can be drawn from using animal models of critical illness to 102 
distinguish such phenotypes, as the responses can be very different to those 103 
seen in humans [5].  An alternative translational approach is to study healthy 104 
humans in extreme environments as an experimental model of physiological 105 
stress [6].  106 
 107 
AUSTERE ENVIRONMENT MODEL OF ADAPTATION TO 108 
PHYSIOLOGICAL STRESS 109 
Without behavioural and technological intervention, human survival is 110 
confined to a narrow range of environmental conditions, based on the 111 
environment in which we originated (the East African Rift). Approximately 3.5 112 
million years ago, early humans walked on land and were subject to tropical 113 
temperatures, the Earth’s gravitational field, barometric pressure associated 114 
with relatively low elevations, and Earth’s geomagnetic field (the 115 
magnetosphere) [7] (Figure 1). Changes in any of these external conditions 116 
will challenge homeostasis [8].  Thus when humans explore new and austere 117 
environments, both on Earth and beyond its boundaries, they are exposed to 118 
physiological stress, to which they must either adapt or succumb.  Like their 119 
counterparts in the critical care unit, healthy individuals show a significant 120 
degree of variation in their ability to tolerate environmental stress [9], and 121 
perhaps some survival mechanisms are common to both scenarios. An 122 
austere environment experimental model offers an approach to further our 123 
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understanding by avoiding the multitude of confounding variables in the 124 
critical care unit.  Studies at high altitude revealed the existence of 125 
physiological acclimatisation to hypoxia within individuals over brief periods of 126 
time [10] and genetic adaptation in high altitude populations over hundreds of 127 
generations [11].  Harnessing these processes may offer an alternative 128 
therapeutic approach to treating the tissue hypoxia commonly seen in critical 129 
illness. Studies of environmental stress have drawn attention to adaptation at 130 
a cellular and molecular level, in addition to the more easily observable 131 
system responses that we currently monitor and target in critical care units. It 132 
is apparent that homeostatic pressures are sensed at a cell level and trigger a 133 
host of cytoprotective responses that preserve function and survival of the 134 
cell, and the organism as a whole [12]. Exploiting cellular adaptation may be 135 
a novel strategy for promoting survival during pathophysiological stress, but 136 
doing so requires improved understanding of how this process occurs in intact 137 
humans, rather than in petri dishes or animal models alone. 138 
 139 
Here we review the manner in which different forms of environmental stress 140 
threaten survival and how humans adapt to them over time.  We propose that, 141 
by improving understanding of what determines survival during exposure to 142 
external stressors, from heat to hypoxia, studies of humans in austere 143 
environments have the potential to transform the practice of critical care 144 
medicine. 145 
 146 
ADAPTATION TO HEAT STRESS 147 
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Excessive heat threatens survival through protein dysfunction and 148 
denaturation. Once membrane p2umps fail, ion gradients dissipate and cells 149 
lose the ability to produce energy or generate the signals vital for survival, 150 
resulting in loss of cell integrity and activation of cell death pathways. This 151 
triggers a systemic inflammatory response that culminates in multi-organ 152 
failure [13, 14]. To protect against this, the acute systemic response to a rise 153 
in core temperature (due to internal or external processes that alter the 154 
balance of heat generation and dissipation) diverts blood flow to the 155 
peripheries to increase heat loss to the environment. If ambient temperature 156 
exceeds 37oC, the only way to lose heat is through sweat production. 157 
However, this compensation occurs at the cost of intravascular volume 158 
depletion and cardiovascular instability if fluid is not replaced. Above a body 159 
temperature of 40-41oC the neurones that coordinate the systemic response 160 
are themselves compromised and compensation fails, leading to heat stroke 161 
and death [15].  162 
Tolerance to heat stress varies between individuals [16], with the elderly and 163 
newborn being particularly vulnerable [17]. Individual tolerance to heat stress 164 
can be improved by repeated exposure to sub-lethal temperatures. This is 165 
known as heat acclimation, and requires two to six weeks of continuous or 166 
intermittent heat exposure to be effective [18]. The process increases 167 
exercise capacity of individuals in hotter environments and can double the 168 
time to reach a state of physical exhaustion [19].  Acclimated individuals can 169 
tolerate higher core temperatures and experience less cardiovascular strain 170 
during exercise.  Athletes, whose muscles regularly reach temperatures of 171 
44C during intense exercise [20], are capable of tolerating core temperatures 172 
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of 39.5 – 40C for short periods [21], while untrained individuals demonstrate 173 
heat exhaustion at 38C [19].  Despite having higher sweat rates, 174 
intravascular volume and cardiovascular stability is preserved through 175 
minimisation of salt loss in sweat and urine [22]. Native populations of hot 176 
environments, such as the Bushmen of the Kalahari desert, have enhanced 177 
exercise capacity in hot conditions compared to non-natives, and maintain 178 
lower core temperatures despite paradoxically lower sweat rates [23]. This 179 
implies that they possess alternative thermoregulatory mechanisms, perhaps 180 
genetically determined, that counteract the rise in core temperature while 181 
circumventing the physiological strain of dehydration.  182 
 183 
Part of the heat acclimation process may be occurring at a cellular level. Heat 184 
stress activates a set of constitutively expressed transcription factors, which 185 
regulate the expression of heat shock proteins (HSP) [20]. HSPs protect the 186 
cell from impending heat-induced injury by various mechanisms: scavenging 187 
free radicals, eliminating harmful metabolic products and acting as molecular 188 
chaperones. For example, HSP72 and HSP90 bind to damaged polypeptides 189 
and restore their native structure or assist in their disposal, preventing 190 
aggregation within the cell [24]. This defence strategy can also be activated 191 
by other forms of stress common in critical illness, from energy depletion to 192 
hypoxia [25]. The cellular heat shock response is reduced in the elderly [26], 193 
who are notably more susceptible to the effects of physiological stress. As 194 
such, it represents a potential target for protecting cellular and organ function 195 
without correcting systemic physiological values [27]. One method of 196 
activating this response is though exercise training, which, when it generates 197 
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a sustained increase in body temperature by 1-2oC, can activate a cellular 198 
acclimation responses [24].  This may account for part of the enhanced 199 
physiological reserve observed in physically fit individuals (in addition to their 200 
superior cardiorespiratory function). Cell adaptation may also be triggered 201 
pharmacologically: a molecular activator called BCP-15 increases expression 202 
of HSP72 and improves inflammation and metabolic homeostasis in a rat 203 
model of type 2 diabetes [28].  In the future, administration of such agents 204 
could offer a means of preserving cell integrity and function during critical 205 
illness. In situations where future pathophysiological stress can be predicted, 206 
such as planned major surgery, programmes of exercise or heat acclimation 207 
could be employed to prime the cytoprotective response. There is a need for 208 
further clinical research in this area, which has the potential to extend the 209 
supportive therapy in critical care beyond modification of systemic responses. 210 
 211 
ADAPTATION TO COLD STRESS 212 
The physiological stress of cold exposure occurs through progressive slowing 213 
of vital chemical reactions; the Arrhenius principle states that metabolic rate 214 
will halve for every 10oC decrease in temperature. Diminished activity of ion 215 
channels reduces the rate at which excitable cells can conduct impulses and 216 
death may result from central nervous system dysfunction or cardiac 217 
arrhythmia.  [29] To protect cells against these effects, the body has an acute 218 
systemic response to restore the core temperature: minimising heat loss 219 
through peripheral vasoconstriction and increasing heat generation by 220 
shivering. Below 35oC, the function of the tissues coordinating the systemic 221 
response to cold is impaired, and body will cool to the ambient temperature.  222 
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Like sweating, shivering comes at a physiological cost – in this instance, the 223 
increase in energy requirements.  However, prolonged or repeated cold 224 
exposure results in habituation: with toleration of lower core body 225 
temperatures and shivering triggered at lower temperatures (Macari Dauncey 226 
and Ingram 1983).  Accepting mild core hypothermia to preserve energy is 227 
also seen in native residents of cold environments, such as the circumpolar 228 
Lapps and Inuit [30–32].  Korean ama divers, who are regularly immersed in 229 
10 oC water during the winter, undergo a drop in core temperature to 35 oC 230 
and have a significantly higher shivering threshold than non-divers {Park and 231 
Hong, 1991, #65005}. Survival at this new set point may be facilitated by 232 
increased cellular defences, reminiscent of cellular acclimatisation to heat 233 
stress.  The molecular pathways involved in the cell response to cold stress 234 
are less well described than those for heat.  Repeated cold water immersion 235 
in winter swimmers results in increased expression of antioxidants [34], which 236 
may play a role in this. Specific cold shock proteins have been identified in 237 
mammalian cells [35], while cold exposure also increases expression of 238 
“heat” shock proteins [36–38], demonstrating that the cell may have a general 239 
response to different forms of stress.   240 
 241 
It may be possible to utilise the phenomenon of cross-adaptation (whereby 242 
repeated exposure to one form of environmental stress also results in 243 
adaptation to a different one) to improve clinical outcomes. Subjects exposed 244 
to repeated episodes of cold water immersion demonstrate modification of 245 
their autonomic response to subsequent exposure to hypoxia [39].  Although 246 
prehabilitation prior to unexpected critical illness is not usually feasible, a 247 
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significant proportion of patients classified as high risk prior to major elective 248 
surgery go on to develop postoperative complications which can spiral into 249 
critical illness and multiple organ failure [40].  Heat or cold-acclimatisation 250 
programmes, by upregulating cell protective mechanisms, could enhance 251 
tolerance prior to a planned episode of stress, such as major surgery, and 252 
potentially improve outcomes in these patients.  Furthermore, the systemic 253 
stress response to surgical trauma, which has been blamed for adverse 254 
outcomes following surgery, including: cardiovascular instability, ischaemia, 255 
fluid overload, hyperglycaemia, wound infections and thromboembolism [41], 256 
has many direct parallels with the acute response to cold exposure. Repeated 257 
controlled exposure to cold blunts the acute response, resulting in reduced 258 
circulating levels of catecholamines, cortisol and glucose on subsequent 259 
exposure to cold [42, 43], and further study is required to discover if such a 260 
programme could improve outcomes after surgery. 261 
 262 
ADAPTATION TO HYPOXIA 263 
Mitochondria require a continuous supply of oxygen to meet up to 98% of the 264 
body’s energy demands through the process of oxidative phosphorylation. 265 
Tissue hypoxia therefore results in cellular energetic failure, as well as cell 266 
damage through oxidative stress, by increasing the generation of reactive 267 
oxygen species [44]. As barometric pressure declines on ascent to high 268 
altitude (Figure 2), the commensurate decline of oxygen partial pressure 269 
(PO2) reduces the pressure gradient for oxygen diffusion across the alveolar-270 
capillary membrane resulting in hypoxaemia and reduced convective oxygen 271 
delivery. The acute response to environmental hypobaric hypoxia restores 272 
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oxygen delivery, by increasing cardiac output (mainly via an increased heart 273 
rate) and raising the arterial oxygen saturation of haemoglobin through 274 
augmented minute ventilation [45]. At the highest point on Earth (8848m), 275 
atmospheric pressure and PO2 are one third of that at sea level [46] and 276 
sudden exposure to this degree of atmospheric hypoxia leads to 277 
unconsciousness and death within minutes [47]. In contrast, with repeated 278 
exposure to sub-lethal levels of hypoxia, humans undergo acclimatisation that 279 
make it possible to summit Mount Everest, in some instances even without 280 
supplemental oxygen. System level acclimatisation to sustained hypoxaemia 281 
consists of increased minute ventilation, heart rate and haemoglobin 282 
concentration, which restore arterial oxygen content to sea level values up to 283 
altitudes of 7100 m [48]. As with other environments, the extent to which 284 
acclimatisation at the system level can support survival is ultimately limited. 285 
Increases in cardiac output and minute ventilation are energy inefficient in a 286 
situation where oxygen is scarce [49]. Also, an inexorable rise in haemoglobin 287 
concentration will limit oxygen delivery through viscosity-related restriction of 288 
microcirculatory blood flow [50, 51].   289 
 290 
Beneath the surface, however, a myriad of cellular changes occurs in 291 
response to hypoxia, preparing cells for an impending oxygen drought. At 292 
altitude we have observed skeletal muscle atrophy [52], down-regulation in 293 
the production of proteins and autophagy [53]; down-regulation of 294 
mitochondrial biogenesis and decreased expression of electron transport 295 
chain complexes [54]; decreased cardiac phosphocreatine / ATP ratio; and 296 
insulin resistance that correlates to the degree of oxidative stress [55]. All of 297 
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these point towards a state of cellular quiescence, which minimises energy 298 
utilisation. This phenotype may resemble what we see in critical illness [56, 299 
57], yet it is customary in current practice to push the metabolic pendulum in 300 
the opposite direction, pouring oxygen, blood, fluids and inotropic agents into 301 
stressed patients. Using the model of high altitude acclimatisation to 302 
understand how cellular networks in healthy subjects are modified to tolerate 303 
hypoxic stress could drive a shift in this practice, towards support of a 304 
hibernation state during critical illness. 305 
 306 
The importance of adaptations at the distal end of the oxygen cascade is 307 
further emphasised by studies of native high altitude populations. Tibetans 308 
have occupied high altitude for the longest period of time (at 4500m for up to 309 
20,000 years) and arguably represent the pinnacle of human hypoxic 310 
adaptation. As such their cellular phenotype may represent a target to be 311 
emulated therapeutically in order to improve outcomes in the critically ill. 312 
Contrary to popular belief, Tibetans do not exhibit a raised haemoglobin 313 
concentration at high altitude [58], but instead have enhanced function of the 314 
peripheral microcirculatory-mitochondrial unit.  Their capillary density and 315 
microcirculatory blood flow is higher, in conjunction with elevated levels of 316 
nitric oxide products (such as nitrate, nitrite and nitroso proteins) in peripheral 317 
blood [59, 60]. They may also have more efficient mitochondrial metabolism, 318 
demonstrated by greater maximal oxygen consumption normalised to 319 
mitochondrial volume, despite lower mitochondrial density [59]. Some light 320 
has been shed on underlying molecular mechanisms, with a suggestion that 321 
Tibetans undergo a metabolic switch away from the more oxygen-expensive 322 
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substrates, preferring carbohydrate over lipid oxidation [61]. They possess 323 
enhanced cellular defences against oxidative stress, with reduced lipofuscin 324 
accumulation in muscle at high altitude [62]. Superior adaptive mechanisms 325 
appear to have a genetic basis, with natural selection demonstrated in many 326 
genes involved in the hypoxia inducible factor (HIF) pathway, which is 327 
responsible for sensing and coordinating the response to hypoxia in almost 328 
every living creature on earth [63]. Hypoxia stabilises the HIF heterodimer, 329 
which moves to the nucleus and activates the transcription of genes with 330 
hypoxia response elements in their promoter regions, regulating production of 331 
proteins such as erythropoetin and vascular endothelial growth factor. HIF 332 
also reduces the expression of peroxisome proliferator-activated receptor 333 
alpha (PPARα), and this pathway may mediate enhancements in metabolic 334 
efficiency, through downstream actions on fatty acid oxidation and 335 
mitochondrial coupling [64]. 336 
 337 
ADAPTATION TO MICROGRAVITY 338 
Microgravity is a form of environmental stress for astronauts on board the 339 
international space station (ISS); it results from orbiting the Earth in 340 
continuous free-fall.  However, prolonged six degree head-down tilt in a 341 
supine individual mimics almost all of the cardiovascular and musculoskeletal 342 
disturbances of microgravity [65], and many can be observed in bedbound 343 
critically ill patients.  Unlike thermal and hypoxic stress, the effects of 344 
microgravity do not impose a defined limit on human survival, even after 468 345 
days in space [66].  Interestingly, in this case, it is the adaptation itself (to the 346 
stressor imposed by the new environment) that results in almost complete 347 
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incapacitation of the astronaut on return to Earth.  The negative 348 
consequences of adaptation to weightlessness could be easily overlooked 349 
during the storm of other active insults affecting critically ill patients, but 350 
observing this phenomenon in otherwise healthy astronauts highlights the 351 
magnitude of the problem. Understanding the mechanisms underlying this 352 
“mal-adaptation” could prove to be extremely valuable in future active 353 
promotion of recovery and rehabilitation, and studying space travellers may 354 
be the best approach for doing so [65]. 355 
 356 
In a microgravity environment, the hydrostatic pressure difference between 357 
the upper and lower extremities (90 mmHg increase from head to foot) 358 
normally created by the Earth’s gravitational force while in the upright position 359 
is abolished and body fluid shifts upwards from the lower extremities. This is 360 
misinterpreted by baroreceptors as an increase in overall fluid volume, driving 361 
an inappropriate diuresis. Plasma volume and cardiac output progressively 362 
decline with time spent in microgravity, with stroke volume decreasing by up 363 
to 30% [67]. On Earth, every time we stand, the gravity-induced drop in blood 364 
pressure is compensated for by the baroreceptor reflex. In the absence of this 365 
trigger during months in space, baroreceptor sensitivity becomes blunted and 366 
vagal-cardiac activity decreases [68] {Nyhan et al., 2002, #90805} and this has 367 
been associated with endothelial dysfunction {Coupé et al., 2009, #10917}. 368 
The same problems compound prolonged critical illness, resulting in 369 
orthostatic intolerance, which can significantly impede rehabilitation [69].   370 
  371 
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Bone and muscle are dynamic structures, continually remodelling in response 372 
to changing mechanical loads. Diminishing gravitational force interferes with 373 
osteoblast/osteoclast activity and results in bone demineralisation, with the 374 
greatest impact on the weight-bearing bones [70]. On the international space 375 
station (ISS), bone mineral density has been shown to decline by 1% per 376 
month and full recovery from a four-month mission takes years [71].  The 377 
mechanism is not fully understood, but we know that weightlessness results in 378 
calcium loss {Michel et al., 1976, #2783}, and that the demineralisation can be 379 
abated by inhibitors of osteoclast-mediated bone resorption [72]. Astronauts 380 
also suffer a substantial loss of muscle mass and power [73]. Postural 381 
muscles are particularly sensitive and undergo a dramatic loss in type I (slow 382 
twitch) fibres. Studies in rats following a 16 days in space revealed a pathway 383 
for the degradation of these proteins. Supplementation of their diet with the 384 
antioxidant, cysteine, reduced oxidative stress, protein ubiquitination and 385 
muscle loss [74, 75]. Microgravity also leads to atrophy of cardiac muscle, 386 
resulting in diastolic dysfunction, orthostatic intolerance, and increased 387 
incidence of arrhythmia in long-term space residents [76]. 388 
 389 
The devastating deconditioning of physically fit astronauts in microgravity 390 
mirrors the effects of prolonged passivity in critical illness [77]. Given the 391 
multitude of active insults afflicting these patients, it is easy to overlook the 392 
insidious development of orthostatic intolerance or the silent but relentless 393 
wasting of bone and muscle. It has been shown that 92% of critically ill 394 
patients undergo bone hyper-resorption after only one month [78] and muscle 395 
wasting can reach rates of up to 2% per day [79]. The molecular mechanisms 396 
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underlying these processes may be obscured by pathological processes in 397 
critical illness, but studying otherwise healthy human explorers of the most 398 
alien environment of all may assist in the search for targets for therapeutic 399 
intervention. 400 
 401 
CLINICAL CONUNDRUMS AND NEW PARADIGMS 402 
Pathophysiological stress threatens human survival during critical illness and 403 
multiple organ failure. Harnessing innate biological responses to stress, which 404 
are more complex and elegant than any current manmade intervention, may 405 
be the future of critical care medicine. The difficulties we face are: 406 
understanding the myriad of responses to disease, determining which are of 407 
potential therapeutic value, and how best to support such a multifaceted state 408 
effectively. With regard to the latter our traditional approach has been to 409 
intervene at the system or organ level, to maintain measures such as global 410 
oxygenation or haemodynamics within a ‘normal’ range, defined by that seen 411 
in health.  However, meeting such targets in patients with established critical 412 
illness has not been consistently associated with improved outcomes and 413 
striving to achieve them may be associated with harm, either through 414 
bystander effects of the methods used [80] or the tendency towards supra-415 
normalisation of values. Thus we have already started to see a relaxation of 416 
target parameters, with permissive anaemia, hypercarbia and hypoxaemia, in 417 
some cases improving outcomes [81–84].   418 
 419 
It may be that the optimal physiological milieu that fosters health and 420 
regeneration in critically ill patients is different from that in the unstressed 421 
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subjects on which current ‘standard’ targets are based. We may need to 422 
reconsider what constitutes ‘normal’ in this cohort and begin to develop and 423 
evidence base to define future targets. However, determining which 424 
phenotypes are associated with better outcomes, and are thus worth 425 
supporting through medical intervention, is hindered by the mass of 426 
confounding factors that influence survival in the context of critical illness.  427 
Observations of how humans grow and thrive under profound and prolonged 428 
environmental stress may guide us.  Acclimatisation and genetic adaptation to 429 
different environmental extremes often appear to involve a resetting of 430 
homeostasis to a new set point, which could thus represent valid alternative 431 
approach to emulate in our attempts to promote survival during the sustained 432 
stress of critical illness.  We are now beginning to recognise the importance of 433 
the role of innate intracellular mechanisms, such as the HSP and HIF 434 
systems, in sensing and defending against stress.  The field of chronobiology, 435 
in which the timing of molecular events within the cell are co-ordinated by 436 
global rhythms, is now emerging as a significant factor influencing physiology 437 
in critical illness [85].  These ancient cytoprotective responses remain 438 
untapped by current clinical interventions.  Animal models may help to further 439 
our understanding in this field, but they are notoriously unrepresentative of the 440 
human response in some conditions [5]. Humans exposed to physiological 441 
stress in laboratories or in the field could provide a more robust model, in 442 
which the translation to critical illness is more direct.  The phenomenon of 443 
cross-adaptation, in which acclimatisation to one form of stress (such as heat) 444 
can improve tolerance to another (such as hypoxia), through activation of a 445 
common adaptive pathway, may represent an new strategy for pre-446 
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habilitation, and although difficult to utilise in unpredicted critical illness, it 447 
could improve outcomes prior to predictable episodes of stress, such as high 448 
risk surgery, the complications of which commonly lead to critical illness and 449 
multiple organ failure. Finally, understanding the molecular mechanisms 450 
underlying the “mal-adaptation” to sustained exposure to microgravity, the 451 
consequences of which are problematic during recovery and rehabilitation, 452 
appear to be of increasing importance.  Space medicine has not just 453 
highlighted the extent of deconditioning produced by weightlessness, 454 
independently of disease, but the investment in technology and pharmacology 455 
to circumvent this problem during prolonged spaceflight could have a direct 456 
application in critical care units [86].  457 
 458 
CONCLUSION 459 
New insights into how the human body adapts to physiological stress in 460 
austere environments may provide the key to promoting survival during critical 461 
illness.  The practice of intensive care, traditionally limited to intervention at 462 
the system and organ level to achieve phenotypes seen in health, may one 463 
day extend to harnessing the innate cytoprotective response. 464 
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FIGURES 753 
 754 
Figure 1. The main physiological constraints determining human survival on 755 
Earth.  756 
 757 
 758 
 32 
Less than a sixth of the Earth’s surface can be permanently inhabited; the rest 759 
is either covered by water or lies outside the tolerable zones of pressure and 760 
temperature. Away from the Earth's surface, gravity and the protective effect 761 
of the magnetosphere are dramatically diminished. 762 
 763 
 764 
 765 
Figure 2. The decline in barometric pressure (PB) on ascent to altitude.  PB 766 
determines the oxygen partial pressure at any given altitude.  767 
 768 
 769 
 770 
The summit of Mt Everest (8848m) is close to the limit of human tolerance to 771 
hypoxia and the Armstrong limit line is the altitude at which free water 772 
spontaneously vaporises.  773 
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